Prevalence Of Oral Mucosal Alterations In Diabetes Mellitus Type2
NCT ID: NCT03670797
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2018-12-25
2019-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Type 2 Diabetes in Fayoum
NCT03683784
Prevalence of Upper Limb Musculoskeletal Abnormalities in Type 2 Diabetic Patients and Its Relation to Hypoglycemic Control.
NCT05819671
Adherence and Beliefs About Medications, and Illness Perception Among Type 2 Diabetic Patients in Assiut Main Hospital
NCT05301855
Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.
NCT03154398
Tongue Fur and Metabolites in Diabetes Mellitus
NCT04909632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Selection bias: will be minimized by enrolling the participants in the study in a consecutive order of the entering the clinic.
Non-respondent bias: will be minimized by explaining to the participants the aim of the study and their importance and role in the study.
Incomplete records: will be excluded from statistical analysis with reporting the cause of not completing the record.
Sample size estimation:
Based on the previous papers by AL-Maweri,et al ,2013, the prevalence of oral mucosal alterations in diabetic patients 45.1%.Using a precision of 5, a design effect set at 1 with 95% CI (confidence interval), a total sample size of 381 will be sufficient. The sample size was calculated by Epi info.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
controlled diabetic patients
No interventions assigned to this group
uncontrolled diabetic patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients \>25years old
3. Patients diagnosed with diabetes type 2.
4. Egyptian patients.
Exclusion Criteria
2. Patients not physically able to participate in survey or clinical oral examination.
3. Patients with other systemic diseases which may cause oral manifestation as liver disorders.
4. Patients under immunosuppressive drugs.
5. Patients under corticosteriods.
6. Patients with organ transplantation.
25 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Alaa Mahmoud abd El kader
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Mahmoud abd El kader
principle investigator, internal resident at oral medicine department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariam fakhr
Role: STUDY_CHAIR
the Endocrine units at the Kasr Al-Ainy Cairo university hospital.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaa Mahmoud Abd El Kader
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci. 2013 Jul;20(4):39-46.
Bastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011 Apr;92(1):100-5. doi: 10.1016/j.diabres.2011.01.011. Epub 2011 Mar 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diabetes-Oral Alterations
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.